Probe Into FDA Monitoring Of Whistleblower Emails Expands
The U.S. Office of Special Counsel said Wednesday it is broadening its investigation into the U.S. Food and Drug Administration's treatment of employees who alerted the Obama administration to perceived FDA...To view the full article, register now.
Already a subscriber? Click here to view full article